In November of this year the Nephrology World converged Orlando, Florida for Kidney Week. It had been two years since this meeting had been in person.
The Filtrate:
Joel Topf
Swapnil Hiremath
Nayan Arora
Sophia Ambruso
Editor:
Nayan Arora
Show Notes:
Joel’s Conflict of Interest Statement
EMPA-Kidney is “off the board”
Lunch Symposium on Current and Future Approaches to the Diagnostic Assessment and Management of AKI in Patients with Cirrhosis provided by an educational grant from Mallinckrodt Pharmaceuticals
The CONFIRM Trial Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome in NephJC
Clinical Practice Session Leveraging Social Media to Create, Learn, Teach, Advocate, and Dispel Misinformation
The BEST-Fluids Trial: A Randomized Controlled Trial of Balanced Crystalloid Solution vs. Saline to Prevent Delayed Graft Function in Deceased Donor Kidney Transplantation - Michael G. Collins, Magid Fahim, Elaine Pascoe, Carmel Hawley, David W. Johnson, Philip A. Clayton, Steven J. Chadban (ClinicalTrials.gov)
The Late Breaking and High Impact Trials Session line up
Stop ACEi
Effects of Pantoprazole on Kidney Outcomes: Post Hoc Analyses From the COMPASS Randomized Controlled Trial by Lonnie Pyne, et al
No Stone: Hydrochlorothiazide for the Prevention of Kidney Stone Recurrence by Daniel Foster, et al
Clinical Practice Session Best of NephJC
“We'd Now Like To Open The Floor To Shorter speeches disguised as questions.”
